X0306 4 2022-10-17 0 0001823239 MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI 0001949513 MARTIN WILLIAM E. III C/O MARAVAI LIFESCIENCES HOLDINGS, INC. 10770 WATERIDGE CIR, SUITE 200 SAN DIEGO CA 92121 0 1 0 0 See remarks Class A Common Stock 2022-10-17 4 A 0 120019 A 120019 D Class A Common Stock 2022-10-17 4 A 0 228036 A 348055 D Employee Stock Option (Right to Buy) 19.42 2022-10-17 4 A 0 403946 0.00 A 2032-10-17 Class A Common Stock 403946 403946 D Performance Stock Units 2022-10-17 4 A 0 240038 0.00 A 2025-10-17 Class A Common Stock 240038 240038 D Represents restricted stock units ("RSUs") awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan (the "Omnibus Incentive Plan"). Each RSU represents the right to receive one share of Class A Common Stock of the Issuer upon vesting, subject to the Reporting Person's continued employment with the Issuer. The RSUs will vest 50% on each of October 17, 2023 and October 17, 2024, subject to the Reporting Person's continued employment with the Issuer. Represents RSUs awarded under the Omnibus Incentive Plan. Each RSU represents the right to receive one share of Class A Common Stock of the Issuer upon vesting, subject to the Reporting Person's continued employment with the Issuer. The RSUs will vest in 1/3rd increments on each of October 17, 2023, October 17, 2024, and October 17, 2025, subject to the Reporting Person's continued employment with the Issuer. Represents options awarded under the Omnibus Incentive Plan. These options will vest 25% on October 17, 2023 and in near-equal 1/36th installments each month thereafter, subject to the Reporting Person's continued employment with the Issuer. Represents performance stock units ("PSUs") awarded under the Omnibus Incentive Plan. Each PSU represents the contingent right to receive one share of Class A Common Stock of the Issuer. The PSUs will vest on October 17, 2025, if and to the extent the 60-trading day volume-weighted average stock price of the Class A Common Stock of the Issuer equals or exceeds certain thresholds, provided that in the event of a Change in Control (as defined in the Omnibus Incentive Plan) prior to October 17, 2025, the PSUs will convert to time-based RSUs that will fully vest on October 17, 2025, subject to the Reporting Person's continued employment with the Issuer. The Reporting Person was performing the responsibilities of Chief Executive Officer of the Company on October 17, 2022. Effective October 18, 2022, the Reporting Person commenced a temporary leave of absence, and during his leave of absence, the Reporting Person is not expected to perform any responsibilities as Chief Executive Officer of the Company. /s/ Kurt Oreshack, by power of attorney for William E. Martin, III 2022-10-19